Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Astellas Pharma Inc
Lokon Pharma AB
Amgen
Nanjing Leads Biolabs Co.,Ltd
Weill Medical College of Cornell University
Jazz Pharmaceuticals
AbbVie
University of California, San Diego
Trishula Therapeutics, Inc.
Queen's University
Trishula Therapeutics, Inc.
Medical University of Vienna
Spanish Oncology Genito-Urinary Group
Theriva Biologics SL
BPGbio